Jane Street
BJDX icon

Jane Street’s Bluejay Diagnostics BJDX Stock Holding History

Jane Street’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– -$5.01K – 8676
2023
Q1 		– Hold
0
– – – 8811
2022
Q2 		– Hold
0
– -$18K – 9666
2022
Q1 		– Sell
-1
Closed -$48.2K – 9964
2021
Q4 		$61K Buy
+1
New +$98.3K ﹤0.01% 9461

Other funds holding BJDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jane Street's BJDX Position: Q2 2023 in Review

Jane Street held its Bluejay Diagnostics (BJDX) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8676.

Jane Street first reported a position in BJDX in Q4 2021 and has held it in 1 quarter since. The position peaked at $61K in Q4 2021. 4 funds tracked by Wall St. Rank hold BJDX as of Q2 2023.

  • Jane Street held 0 shares of Bluejay Diagnostics worth $0 as of Q2 2023.
  • Jane Street left its Bluejay Diagnostics share count unchanged in Q2 2023.
  • Bluejay Diagnostics made up ﹤0.01% of Jane Street's portfolio in Q2 2023, its #8676 holding.
  • Jane Street first reported a position in Bluejay Diagnostics in Q4 2021 and has held it in 1 quarter since.
  • Jane Street's Bluejay Diagnostics position peaked at $61K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.